ZNTL
:Zentalis Pharmaceuticals Inc *
Snapshot
|
Charting
|
News
|
Options
*
Deficient
:
Issuer Failed to Meet NASDAQ Continued Listing Requirements
$12.07
0.92%
$0.11
NASDAQ
10:36a ET
May 16 '24
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
Newsfile Corp
Last
Change
Exchange
Market data is delayed by at least 15 minutes.
Markets
Portfolio
Symbol Lookup
Latest Story
Top Stories on ZNTL
No News Available
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology I...
7:00a ET May 14 '24
GlobeNewswire
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results...
7:00a ET May 7 '24
GlobeNewswire
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to C...
10:49a ET May 3 '24
Newsfile Corp
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Lis...
5:30p ET May 1 '24
GlobeNewswire
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating ...
4:05p ET April 2 '24
GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Lis...
5:30p ET April 1 '24
GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Lis...
6:00p ET March 1 '24
GlobeNewswire
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferen...
7:00a ET February 28 '24
GlobeNewswire
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and...
7:00a ET February 27 '24
GlobeNewswire
Market data provided by
News provided by